![Jon Pilcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon Pilcher
Directeur Général chez
NEUREN PHARMACEUTICALS LIMITED
Fortune : 21 M $ au 31/10/2026
Profil
Jonathan Charles Pilcher is currently Chief Executive Officer, MD & Director at Neuren Pharmaceuticals Ltd. since 2021.
He is also Director at Agventures Ltd., Neuroendocrinz Ltd., Neuren Pharmaceuticals, Inc., and Neuren Pharmaceuticals (Australia) Pty Ltd., all since 2013.
Former roles include Independent Non-Executive Director at Btc Health Ltd. from 2015 to 2023, Senior Manager at Australia & New Zealand Banking Group Ltd. (Research Firm), and CFO, Secretary & Head-Investor Relations at Acrux Ltd. from 2009 to 2013.
Education includes undergraduate studies at The University of Reading.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/03/2026 | 1 500 000 ( 1,18% ) | 21 M $ | 31/10/2026 |
Postes actifs de Jon Pilcher
| Sociétés | Poste | Début |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Directeur Général | 27/05/2020 |
Agventures Ltd. | Directeur/Membre du Conseil | 30/08/2013 |
Neuroendocrinz Ltd. | Directeur/Membre du Conseil | 30/08/2013 |
Neuren Pharmaceuticals, Inc. | Directeur/Membre du Conseil | - |
Neuren Pharmaceuticals (Australia) Pty Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jon Pilcher
| Sociétés | Poste | Fin |
|---|---|---|
| BTC HEALTH LIMITED | Directeur/Membre du Conseil | 31/05/2023 |
| ACRUX LIMITED | Directeur Financier/CFO | 16/08/2013 |
Australia & New Zealand Banking Group Ltd. (Research Firm)
 Australia & New Zealand Banking Group Ltd. (Research Firm) Investment ManagersFinance Provides investment research | Corporate Officer/Principal | - |
Formation de Jon Pilcher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Neuren Pharmaceuticals Ltd.
 Neuren Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Manufactures drugs for neurological disorders | Health Technology |
Australia & New Zealand Banking Group Ltd. (Research Firm)
Australia & New Zealand Banking Group Ltd. (Research Firm) Investment ManagersFinance Provides investment research | Finance |
Btc Health Ltd.
 Btc Health Ltd. Investment ManagersFinance Acts as Private Equity Fund | Finance |
Acrux Ltd.
 Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuren Pharmaceuticals, Inc. | |
Neuren Pharmaceuticals (Australia) Pty Ltd. | |
Agventures Ltd. | |
Neuroendocrinz Ltd. |
